Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Sveistrup, Joen ^a   af Rosenschöld, Per M ^a   Deasy, Joseph O ^b   Oh, Jung H ^b   Pommer, Tobias ^a   Petersen, Peter M ^a   Engelholm, Svend A ^a  

^a Rigshospitalet   (Denmark)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Image guided radiotherapy (IGRT); Intensity modulated radiotherapy (IMRT); Prostate cancer; Radiotherapy; Toxicity

Indexed keywords

AGED; DISEASE-FREE SURVIVAL; FIDUCIAL MARKERS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; ORGANS AT RISK; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893207086     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-44     Document Type: Article

References (22)

1. Mottet N, Peneau M, Mazeron JJ, et al. Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial. Eur Urol 2012, 62(2):213-219. 10.1016/j.eururo.2012.03.053, 22502942.
2. Martin JM, Bayley A, Bristow R, et al. Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2009, 4:50. 10.1186/1748-717×-4-50, 10.1186/1748-717X-4-50, 2777178, 19887007.
3. Gill S, Thomas J, Fox C, et al. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011, 6:145. 10.1186/1748-717×-6-145, 10.1186/1748-717X-6-145, 3217047, 22035354.
4. Zelefsky MJ, Kollmeier M, Cox B, et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2012, 84(1):125-129. 10.1016/j.ijrobp.2011.11.047, 22330997.
5. Engels B, Soete G, Verellen D, et al. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys 2009, 74(2):388-391. 10.1016/j.ijrobp.2008.08.007, 19056185.
6. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280(11):969-974. 10.1001/jama.280.11.969, 9749478.
7. Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendation of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974. 10.1016/j.ijrobp.2006.04.029, 16798415.
8. Bergström P, Löfroth PO, Widmark A. High-precision conformal radiotherapy (HPCRT) of prostate cancer-a new technique for exact positioning of the prostate at the time of treatment. Int J Radiat Oncol Biol Phys 1998, 42(2):305-311. 10.1016/S0360-3016(98)00229-6, 9788408.
9. Fransson P, Bergström P, Löfroth PO, et al. Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath technique. Int J Radiat Oncol Biol Phys 2006, 66(2):430-438. 10.1016/j.ijrobp.2006.05.007, 16904846.
10. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001, 58(6):843-848. 10.1016/S0090-4295(01)01441-8, 11744442.
11. Aznar MC, Petersen PM, Logadottir A, et al. Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 2010, 97(3):480-484. Epub 2010 Oct 20, 10.1016/j.radonc.2010.09.014, 20970215.
12. Schallenkamp JM, Herman MG, Kruse JJ, et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005, 63(3):800-811. 10.1016/j.ijrobp.2005.02.022, 16199313.
13. Guckenberger M, Ok S, Polat B, et al. Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 2010, 186(10):535-543. 10.1007/s00066-010-2144-z, 20890743.
14. McLaughlin PW, Troyer S, Berri S, et al. Functional anatomy of the prostate: implications for treatment planning. Int J Radiat Oncol Biol Phys 2005, 63(2):479-491. 10.1016/j.ijrobp.2005.02.036, 16168840.
15. Fransson P, Bergström P, Löfroth PO, et al. Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath technique. Acta Oncol 2003, 42(4):326-333. 10.1080/02841860310004346, 12899504.
16. Albert M, Tempany CM, Schultz D, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003, 98(5):949-954. 10.1002/cncr.11595, 12942561.
17. Lawton CA, Bae K, Pilepich M, et al. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. Int J Radiat Oncol Biol Phys 2008, 70(2):437-441. 10.1016/j.ijrobp.2007.06.050, 2917176, 17881145.
18. Diez P, Vogelius IS, Bentzen SM. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer. Int J Radiat Oncol Biol Phys 2010, 77(4):1066-1071. 10.1016/j.ijrobp.2009.06.013, 2891420, 19880260.
19. Pinkawa M, Pursch-Lee M, Asadpour B, et al. Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion. Strahlenther Onkol 2008, 184(12):679-685. 10.1007/s00066-008-1902-7, 19107350.
20. Langsenlehner T, Döller C, Winkler P, et al. Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy. Strahlenther Onkol 2013, 189(4):321-328. 10.1007/s00066-012-0303-0, 23443612.
21. Spratt DE, Pei X, Yamada J, et al. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2012, 12. [Epub ahead of print].
22. Abdollah F, Schmitges J, Sun M, et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol 2012, 19(9):836-844. 10.1111/j.1442-2042.2012.03052.x, 22574746.